Discovery Park - Bindley Bioscience Center

Two Purdue Faculty Elected to Medical and Biological Engineering Elite

Thu, 15 Dec 2011 00:00:00 GMT

The American Institute for Medical and Biological Engineering (AIMBE) has recently announced the election of 107 members to the College of Fellows. The inductees, who were nominated by their peers, were screened by committees of Fellows within their specialty and were finally elected by the full College as the official Class of 2012.

C-GRIID to host a special networking event

Wed, 10 Aug 2011 00:00:00 GMT

"RFA Networking Social Event" on Tuesday, August 16th at 4pm.

High school students to participate in USA Biology Olympiad National Finals

Fri, 27 May 2011 00:00:00 GMT

For the second consecutive year, top high school students will travel to Purdue University to participate June 5-17 in the ninth annual USA Biology Olympiad National Finals, sponsored by the Center for Excellence in Education. Team USA members earned gold medals at the last four International Biology Olympiad competitions, including in 2010 after their USA qualifying activities at Purdue.

Interim Administrative Changes at the Bindley Bioscience Center

Fri, 22 Apr 2011 00:00:00 GMT

Charles Buck, Director of Operations has accepted a position outside of Purdue University. We wish him the best of luck in his future endeavors and thank him for all of the contributions he made to the success of the Bindley Bioscience Center. He has made a real difference for the Bindley Bioscience Center and Discovery Park. We are pleased to announce....

MILabs imaging instrument to help Purdue expand life sciences research

Wed, 09 Feb 2011 00:00:00 GMT

WEST LAFAYETTE, Ind. - Purdue University's Bindley Bioscience Center has installed a high-end imaging instrument to advance research in the areas of cancer, neuroscience, and cardiovascular and musculoskeletal diseases. The MILabs U-SPECT-II/CT system, manufactured by MILabs B.V. of The Netherlands, will be used by researchers at the Discovery Park life sciences facility to capture detailed molecular and anatomical images for precision analysis, particularly for medical research.

Team creates 'engineered organ' model for breast cancer research

Tue, 25 Jan 2011 00:00:00 GMT

The model mimics the branching mammary duct system, where most breast cancers begin, and will serve as an "engineered organ" to study the use of nanoparticles to detect and target tumor cells within the ducts. Sophie Leli�vre, associate professor of basic medical sciences in the School of Veterinary Medicine, and James Leary, SVM Professor of Nanomedicine and professor of basic medical sciences in the School of Veterinary Medicine and professor of biomedical engineering in the Weldon School of Biomedical Engineering, led the team.

New solar cell would self-repair like natural plant systems

Wed, 05 Jan 2011 00:00:00 GMT

Researchers are creating a new type of solar cell designed to self-repair like natural photosynthetic systems in plants by using carbon nanotubes and DNA, an approach aimed at increasing service life and reducing cost. "We've created artificial photosystems using optical nanomaterials to harvest solar energy that is converted to electrical power," said Jong Hyun Choi, an assistant professor of mechanical engineering at Purdue Univ.

Imaging tool may aid nanoelectronics by screening tiny tubes

Wed, 17 Nov 2010 00:00:00 GMT

WEST LAFAYETTE, Ind. - Researchers have demonstrated a new imaging tool for rapidly screening structures called single-wall carbon nanotubes, possibly hastening their use in creating a new class of computers and electronics that are faster and consume less power than today's. The semiconducting nanostructures might be used to revolutionize electronics by replacing conventional silicon components and circuits. However, one obstacle in their application is that metallic versions form unavoidably during the manufacturing process, contaminating the semiconducting nanotubes.

Kylin Therapeutics receives funding for cancer treatment research

Fri, 12 Nov 2010 00:00:00 GMT

Officials of Kylin Therapeutics Inc. announced Wednesday (Nov. 10) that they received a therapeutic discovery project grant from the U.S. Internal Revenue Service that will advance the company's pRNAi nanoparticle cancer treatment research. The nearly $250,000 award from the IRS is in the form of a grant designed for biotechnology research and development that is critical for the advancement of new therapies. The grants are administered through the U.S. Department of Health and Human Services. Kylin's pRNAi is a nanotechnology platform that leverages the power of RNA and a natural process called RNA interference (RNAi) to directly target and "turn off" disease-causing genes.

Company Develops Breast Cancer Return Test

Fri, 22 Oct 2010 00:00:00 GMT

Purdue Research Park company says it has developed a blood test with the potential to detect the recurrence of breast cancer about one year ahead of current technology. Matrix-Bio Inc. says its findings have been published in the peer-reviewed journal Cancer Research. The company is using technology discovered by founder Dan Raftery, who is also a professor of chemistry at Purdue University.